NIH – National Cancer Institute: Integration of Imaging & Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

This opportunity uses the R01 Research Project Grant funding mechanism.

The National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Funding & Duration

Application budgets are limited to US $499,999 (approx. AUD $730,000) in direct costs per year. The maximum project period is 5 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.